Back to SYRE
JPMORGAN CHASE & CO SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
29
Latest value
$169
Q3 2026
Peak value
$106.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $83K |
| Q3 2025 | $3.9M |
| Q3 2025 | $337K |
| Q3 2025 | $333K |
| Q4 2025 | $973K |
| Q4 2025 | $901K |
| Q4 2025 | $187K |
| Q4 2025 | $229 |
| Q1 2026 | $91 |
| Q1 2026 | $270K |
| Q1 2026 | $318 |
| Q1 2026 | $31.2M |
| Q1 2026 | $2.2M |
| Q1 2026 | $10.8M |
| Q2 2026 | $13K |
| Q2 2026 | $43.5M |
| Q2 2026 | $19K |
| Q2 2026 | $4.4M |
| Q2 2026 | $631 |
| Q2 2026 | $51M |
| Q2 2026 | $180 |
| Q3 2026 | $12K |
| Q3 2026 | $32.6M |
| Q3 2026 | $7.7M |
| Q3 2026 | $17K |
| Q3 2026 | $55K |
| Q3 2026 | $106.4M |
| Q3 2026 | $593 |
| Q3 2026 | $169 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $169 | 2 | — | — |
| Q3 2026 | $593 | 7 | — | — |
| Q3 2026 | $106.4M | 1.25M | — | — |
| Q3 2026 | $55K | 645 | — | — |
| Q3 2026 | $17K | 206 | — | — |
| Q3 2026 | $7.7M | 91.5K | — | — |
| Q3 2026 | $32.6M | 384.6K | — | — |
| Q3 2026 | $12K | 140 | — | — |
| Q2 2026 | $180 | 2 | — | — |
| Q2 2026 | $51M | 561.7K | — | — |
| Q2 2026 | $631 | 7 | — | — |
| Q2 2026 | $4.4M | 48.9K | — | — |
| Q2 2026 | $19K | 206 | — | — |
| Q2 2026 | $43.5M | 482.0K | — | — |
| Q2 2026 | $13K | 140 | — | — |
| Q1 2026 | $10.8M | 236.9K | — | — |
| Q1 2026 | $2.2M | 49.5K | — | — |
| Q1 2026 | $31.2M | 687.0K | — | — |
| Q1 2026 | $318 | 7 | — | — |
| Q1 2026 | $270K | 5.9K | — | — |
| Q1 2026 | $91 | 2 | — | — |
| Q4 2025 | $229 | 7 | — | — |
| Q4 2025 | $187K | 5.7K | — | — |
| Q4 2025 | $901K | 27.5K | — | — |
| Q4 2025 | $973K | 29.7K | — | — |
| Q3 2025 | $333K | 19.9K | — | — |
| Q3 2025 | $337K | 20.1K | — | — |
| Q3 2025 | $3.9M | 231.1K | — | — |
| Q3 2025 | $83K | 5.0K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M